CTO
Citius Oncology, Inc. (CTOR) Q2 2024 Earnings
CTOR·Reported December 27, 2024·Before market open
Diluted EPS came in at $-0.07, beat the $-0.08 consensus by $0.01.
Diluted EPS
$-0.07beat by $0.01
Consensus: $-0.08
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Citius Oncology, Inc.'s Q2 2024 earnings report.
Citius Oncology, Inc. (CTOR) reported Q2 2024 earnings on December 27, 2024 before market open.
Citius Oncology, Inc. reported diluted EPS of $-0.07 for Q2 2024.
EPS beat the consensus estimate of $-0.08 by $0.01.
You can read the 10-Q periodic report (0001493152-24-030991) directly on SEC EDGAR. The filing index links above go to sec.gov.